ArticleBritish journal of cancer2025

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis.

M Bloem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.